blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Popular
Elections

Genius — OpenServe

Sponsored

ocrelizumab — latest news, discussion & facts — IJR

ocrelizumab

Topic

ocrelizumab

anti-CD20 monoclonal antibody under development for treatment of B cell leukemia and multiple sclerosis

0members1here now

Ask Genius Site

Feed Discussions About

Loading

Comments

Ask Genius by OpenServe:

Free account · your comment posts right after signup

About ocrelizumab

Ocrelizumab, sold under the brand name Ocrevus, is a medication used for the treatment of multiple sclerosis. It is a humanized anti-CD20 monoclonal antibody. It targets CD20 marker on B lymphocytes and is an immunosuppressive drug. Ocrelizumab binds to an epitope that overlaps with the epitope to which rituximab binds. It is administered by intravenous infusion. The fixed-dose combination ocrelizumab/hyaluronidase is administered by subcutaneous injection.

0

members

1

here now

Coverage spread L30 / C30 / R40

Everything about ocrelizumab →

Live room · 1 here

Be the first in the room — members see you arrive.

Facts from Wikidata (CC0).